Loading the section…
Up to five U.S. securities side by side.
| Metric | FLGTFulgent Genetics, Inc. |
|---|---|
| Price | 20.67 |
| Change | −4.66 % |
| Return, 1 year | −6.16 % |
| Market capitalisation | 569M |
| Price / earnings | — |
| Price / sales | 1.8 |
| Price / book | 0.6 |
| Enterprise value / EBITDA | — |
| Return on equity | −8.42 % |
| Net margin | −26.05 % |
| Revenue, last year | 324M |
| Net income, last year | −84M |
| Revenue growth, year over year | +6.83 % |
| Debt / equity | — |
| Volatility, 30 days | 39.97 % |
| Beta | 0.81 |
| Sector | Health care |
Data: US exchange trading and company filings with the regulator